Göran Stening

882 total citations
18 papers, 711 citations indexed

About

Göran Stening is a scholar working on Organic Chemistry, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, Göran Stening has authored 18 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Psychiatry and Mental health and 5 papers in Infectious Diseases. Recurrent topics in Göran Stening's work include HIV/AIDS drug development and treatment (5 papers), Schizophrenia research and treatment (5 papers) and Bipolar Disorder and Treatment (4 papers). Göran Stening is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Schizophrenia research and treatment (5 papers) and Bipolar Disorder and Treatment (4 papers). Göran Stening collaborates with scholars based in Sweden, United States and United Kingdom. Göran Stening's co-authors include B. Eriksson, S. Stridh, Alfons Misiorny, Erik Helgstrand, Jan Olof Noren, K Stenberg, Lennart Philipson, Bo Öberg, Nils Gunnar Johansson and B. Öberg and has published in prestigious journals such as Science, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Göran Stening

17 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Göran Stening Sweden	12	281	217	198	130	88	18	711
Pavel Kramata United States	12	111 0.4×	124 0.6×	200 1.0×	170 1.3×	22 0.3×	17	598
René Verloes Belgium	15	406 1.4×	260 1.2×	119 0.6×	173 1.3×	21 0.2×	44	849
Yiping Zhu China	16	179 0.6×	189 0.9×	458 2.3×	32 0.2×	50 0.6×	30	1.0k
Helen Taylor United Kingdom	16	181 0.6×	44 0.2×	223 1.1×	51 0.4×	95 1.1×	34	1.3k
E Ross United States	9	240 0.9×	285 1.3×	256 1.3×	55 0.4×	19 0.2×	14	829
Carolyn Napier United Kingdom	12	167 0.6×	485 2.2×	433 2.2×	82 0.6×	74 0.8×	19	1.3k
Patricia Marín‐García Spain	17	174 0.6×	64 0.3×	265 1.3×	35 0.3×	28 0.3×	35	818
Patrick Collins Belgium	10	437 1.6×	140 0.6×	266 1.3×	89 0.7×	61 0.7×	28	791
Robert M. Donahoe United States	20	296 1.1×	272 1.3×	460 2.3×	56 0.4×	16 0.2×	57	1.5k
Sylvie Bisser France	20	651 2.3×	99 0.5×	108 0.5×	20 0.2×	78 0.9×	45	1.0k

Countries citing papers authored by Göran Stening

Since Specialization

Citations

This map shows the geographic impact of Göran Stening's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Stening with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Stening more than expected).

Fields of papers citing papers by Göran Stening

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Stening. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Stening. The network helps show where Göran Stening may publish in the future.

Co-authorship network of co-authors of Göran Stening

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Stening. A scholar is included among the top collaborators of Göran Stening based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Stening. Göran Stening is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Weisler, Richard H., Joseph R. Calabrese, Michael E. Thase, et al.. (2008). Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder. The Journal of Clinical Psychiatry. 69(5). 769–782. 49 indexed citations

Stening, Göran, et al.. (2007). Cross-sectional remission of schizophrenia symptoms with quetiapine compared with haloperidol: An analysis of four randomised, controlled trials. European Psychiatry. 22. S141–S141. 1 indexed citations

Carlsson, Anders S., et al.. (2007). An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms. Human Psychopharmacology Clinical and Experimental. 22(5). 315–325. 19 indexed citations

Brecher, Martin, et al.. (2007). Quetiapine and Long-Term Weight Change. The Journal of Clinical Psychiatry. 68(4). 597–603. 38 indexed citations

Lindström, L., et al.. (1990). A double‐blind comparative multicentre study of remoxipride and haloperidol in schizophrenia. Acta Psychiatrica Scandinavica. 82(S358). 130–135. 18 indexed citations

Tao, Pei‐Zhen, Nils Gunnar Johansson, Göran Stening, Bo Öberg, & R. Datema. (1989). Inhibition of HIV-1 reverse transcriptase by 5′-triphosphates of 5-substituted uridine analogs. Antiviral Research. 12(5-6). 269–278. 5 indexed citations

Bazin, Hervé, Jyoti Chattopadhyaya, R. Datema, et al.. (1989). An analysis of the inhibition of replication of HOV and MULV by some 3′-blocked pyrimidine analogs. Biochemical Pharmacology. 38(1). 109–119. 61 indexed citations

Lindstr�m, Leif H., et al.. (1985). An open study of remoxipride, a benzamide derivative, in schizophrenia. Psychopharmacology. 86(1-2). 241–243. 33 indexed citations

Datema, R., et al.. (1985). The Synthesis and Antiherpetic Activity of DHBG and Some Analogs. Nucleosides and Nucleotides. 4(1-2). 303–303. 3 indexed citations

10.

Larsson, Anna‐Karin, B. Öberg, S. Alenius, et al.. (1983). 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrobial Agents and Chemotherapy. 23(5). 664–670. 42 indexed citations

11.

Eriksson, B., Göran Stening, & Bo Öberg. (1982). Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues. Antiviral Research. 2(1-2). 81–95. 13 indexed citations

12.

Stening, Göran, et al.. (1981). Antiherpes activity of [E]-5-(1-propenyl)-2′-deoxyuridine and 5-(1-propenyl)-1-β--arabinofuranosyluracil. Antiviral Research. 1(4). 213–223. 12 indexed citations

13.

Stening, Göran, et al.. (1980). N-aminoalkylsuccinimides as local anaesthetics. III. 1,2,3,4-Tetrahydronaphthalene-2-, indane-1-, and indane-2-spiro-3'-pyrrolidine-2'-5'-diones.. PubMed. 17(4). 177–82. 1 indexed citations

14.

Stening, Göran, et al.. (1980). N-aminoalkylsuccinimides as local anaesthetics. II. 1,2,3,4-Tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-diones substituted in the aromatic nucleus.. PubMed. 17(4). 169–76. 2 indexed citations

15.

Stridh, S., et al.. (1979). The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus multiplication. Archives of Virology. 61(3). 245–250. 18 indexed citations

16.

Helgstrand, Erik, B. Eriksson, Anna‐Karin Larsson, et al.. (1978). Trisodium Phosphonoformate, a New Antiviral Compound. Science. 201(4358). 819–821. 175 indexed citations

17.

Eriksson, B., Erik Helgstrand, Nils Gunnar Johansson, et al.. (1977). Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate. Antimicrobial Agents and Chemotherapy. 11(6). 946–951. 215 indexed citations

18.

Ross, Svante B., et al.. (1973). Cyclizing compounds. 3. Local anesthetic action of N-(.omega.-haloalkyl)-N-methylaminoaceto-2,6-xylidides. Journal of Medicinal Chemistry. 16(7). 787–790. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact